Your DNA contains all the instructions for building and running your body. But only a small fraction of it actually codes for proteins — the workers that do the real work in your cells. That small fraction is called the exome. Exome sequencing reads just these protein-coding regions, looking for changes that could explain a health condition or predict future disease risk.
What is the exome exactly and how is it different from the whole genome?
The exome makes up about 1 to 2 percent of your entire genome. But that tiny slice contains roughly 85 percent of all known disease-causing mutations. The rest of your genome — the other 98 percent — was once called “junk DNA.” We now know it has regulatory functions, but it does not directly code for proteins.
Your whole genome is about 3 billion base pairs long. The exome is around 30 million base pairs. That difference matters for cost and speed. Sequencing the whole genome still costs more and takes longer to analyze. Exome sequencing gives a focused look at the parts of your DNA we understand best.
Think of it like this. The genome is the entire library. The exome is just the shelf with instruction manuals. Most of the important typos that cause inherited diseases are found in those manuals, not in the other shelves.
What can exome sequencing actually reveal about your health?
Exome sequencing can find genetic variants linked to thousands of known conditions. These include rare diseases like cystic fibrosis, Huntington’s disease, and many forms of inherited cancer. The National Human Genome Research Institute reports that exome sequencing identifies a diagnosis in about 25 to 30 percent of people with suspected genetic conditions who have not been diagnosed by other methods.
It can also reveal carrier status — meaning you carry one copy of a gene variant that could cause disease in your children if your partner carries the same variant. Some labs also report “secondary findings.” These are unexpected results showing risk for conditions unrelated to the original reason for testing, such as certain heart conditions or cancer syndromes.
What exome sequencing cannot do is predict common complex diseases like type 2 diabetes or high blood pressure with any real accuracy. Those conditions involve many genes plus lifestyle and environment. Exome sequencing is not a crystal ball for your future health in general. It is a targeted tool for specific inherited conditions.
Who should consider exome sequencing and why?
Exome sequencing is most useful for people with unexplained symptoms that doctors suspect have a genetic cause. This includes children with developmental delays, intellectual disability, or multiple birth defects. It also includes adults with a strong family history of a specific disease that has not been identified through other testing.
Research published in the New England Journal of Medicine found that exome sequencing provided a diagnosis for 25 percent of children with unexplained genetic conditions who had previously gone through standard testing without answers. For some families, that diagnosis ends a diagnostic odyssey that lasted years.
Some people also choose exome sequencing through direct-to-consumer services. This is where caution matters. The American College of Medical Genetics and Genomics advises that exome sequencing should only be ordered and interpreted by a qualified medical professional. The risk of misinterpretation is real when you read raw data without clinical context.
What are the limitations and risks of exome sequencing?
Exome sequencing has clear limits. It does not read the entire genome. It misses mutations in non-coding regions that can still cause disease. It also cannot detect all types of genetic changes. Large deletions, repeats, and structural rearrangements can be invisible to standard exome sequencing.
There is also the problem of variants of uncertain significance. This means the lab finds a genetic change but does not know if it causes disease. A study in Genetics in Medicine found that about 20 to 30 percent of exome results include at least one variant of uncertain significance. This can create anxiety without clear answers.
False reassurance is another risk. A negative exome result does not mean you have no genetic condition. It means no known disease-causing variant was found in the protein-coding regions. The condition could still be caused by something in the non-coding genome or by a gene we have not yet linked to that disease.
How does exome sequencing compare to whole genome sequencing?
These two tests serve different purposes. The table below shows the key differences.
| Feature | Exome Sequencing | Whole Genome Sequencing |
|---|---|---|
| What it reads | Protein-coding regions only (1-2% of DNA) | All 3 billion base pairs |
| Diagnostic yield | About 25-30% for suspected genetic conditions | Slightly higher, especially for non-coding variants |
| Cost | Lower (typically $400-$1,000) | Higher (typically $1,000-$3,000) |
| Analysis time | Faster due to smaller data set | Slower due to massive data |
| Best use | Suspected rare genetic disease | Complex cases where exome was negative |
Whole genome sequencing catches some things exome sequencing misses. But for most people with suspected genetic conditions, exome sequencing is the recommended first step. The Centers for Disease Control and Prevention notes that whole genome sequencing is typically reserved for cases where exome sequencing has already been done without a diagnosis.
What should you know before getting exome sequencing?
Genetic counseling before testing is essential. A counselor explains what results you might get, what they mean, and how they could affect your family. This is not optional — it is standard medical practice for good reason.
You should also understand that results can have implications for your relatives. A finding in a gene linked to hereditary cancer means your siblings or children might carry the same variant. Some people prefer not to know this information. That is a valid choice.
Privacy is another concern. The Genetic Information Nondiscrimination Act of 2008 protects against discrimination by health insurers and employers. But it does not cover life insurance, disability insurance, or long-term care insurance. Some states have additional protections. Check your local laws before testing.
Frequently Asked Questions
How long does it take to get exome sequencing results?
Most clinical labs return results in 8 to 16 weeks. The analysis process is complex and requires comparing your DNA to reference databases.
Can exome sequencing detect cancer risk?
Yes, it can find inherited variants in genes like BRCA1, BRCA2, and others linked to hereditary cancer syndromes. It does not detect cancer itself.
Is exome sequencing covered by insurance?
Many insurance plans cover it when ordered by a doctor for a suspected genetic condition. Coverage varies widely so check with your provider before testing.
Can exome sequencing tell you your ancestry?
No, exome sequencing is designed to find disease-causing variants, not ancestry markers. Ancestry testing uses different methods and reads different parts of the genome.

